Home › NDC Lookup › Ingredients › Cimetidine › 63029-0222-09
Tagamet Cimetidine 200 mg Tablet, 90-count — NDC 63029-0222-09 package photo
Label image from the product's FDA listing (DailyMed) — may show a different pack size or an older label revision.

Tagamet Cimetidine 200 mg Tablet, 90-count — NDC 63029-222-09 (Billing 63029-0222-09)

by Medtech Products Inc. · 1 BOTTLE in 1 CARTON / 90 TABLET in 1 BOTTLE

This is a package of 90 tablets of Tagamet Cimetidine 200 mg Tablet from Medtech Products Inc., marketed since Jun 2012 and currently FDA-listed.

NDC 63029-0222-09
🏷️ FDA NDC (as labeled) 63029-222-09 billing pads the product segment with a zero
This package
Contains90-count Pack sizes10 compare ↓
Product page 63029-0222-01 Also comes in: 6 tablets 63029-222-02 12 tablets 63029-222-12 30 tablets 63029-222-01 36 tablets 63029-222-05 40 tablets 63029-222-04 50 tablets 63029-222-03 70 tablets 63029-222-06 70 tablets 63029-222-70 100 tablets 63029-222-11
OTC Brand On market Non-controlled ⇄ Compare with another NDC
🗂️ FDA directory synced Oct 1, 2026 · this listing last changed Jul 24, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →

This page is curated, coded, and maintained by

Compiled from public FDA, CMS, DailyMed, NADAC, and related drug data sources. Editorial policy

Identity & classification

Regulatory identifiers FDA, NLM and CMS codes for this package

FDA NDC (as labeled) 63029-222-09
Product NDC 63029-222
11-digit billing NDC 63029022209
RxCUI 104062, 197505
UNII 80061L1WGD
Application # NDA020238
SPL Set ID e6401e0a-8612-42e8-bf89-2d67243f28dc
Established class (EPC) Histamine-2 Receptor Antagonist
Mechanism of action Histamine H2 Receptor Antagonists
DEA schedule Non-controlled
Marketing category NDA
Marketing status On market
FDA listing status Listed (active directory)
Marketing start 2012-06-01
Route ORAL
Dosage form TABLET
Substance CIMETIDINE
Quick answers
  • RxCUI (RxNorm): 104062
Why two NDCs? The FDA registers this code as 63029-222-09 — a 5-3-2 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the product segment → 63029-0222-09. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

RxNorm drug class

This medicine belongs to the Histamine-2 Receptor Antagonist class.

Pharmacologic class Histamine-2 Receptor Antagonist
Drug family (ATC) H2-receptor antagonists
How it works Histamine H2 Receptor Antagonists
Where does this data come from?
Therapeutic classes from RxNorm RxClass (U.S. National Library of Medicine) — Established Pharmacologic Class (FDA), ATC drug family (WHO) and mechanism of action, matched by this product’s RxCUI.

Clinical

📗 Our plain-language guide HelloPharmacist
  • It lowers stomach acid. The over-the-counter tablets relieve and prevent heartburn. Prescription forms treat duodenal and gastric ulcers, erosive GERD and conditions with too much...
  • Swallow it by mouth. For over-the-counter tablets, take one with water to relieve heartburn, or up to 30 minutes before a meal that triggers it. Don't take more than 2 tablets in 2...
  • Mild diarrhea, headache, dizziness or sleepiness are possible. Call your doctor if you feel confused, develop a severe rash, or notice signs of allergic reaction.
  • Check with me first. Cimetidine can raise levels of several drugs, including warfarin, phenytoin, theophylline and lidocaine. Ketoconazole should be taken at least 2 hours before i...
📖 Read our full Cimetidine guide →
7
Nutrient depletion considerations

Cimetidine may be associated with lower levels of 7 nutrients — worth a chat with your pharmacist, not a cause for alarm.

🧪 Full Cimetidine nutrient depletion report →
An association is not a deficiency. Educational only — don't start or stop anything without professional guidance.
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price systemPer eachPer package
Retail pharmacies payNADAC · weekly Not in the retail survey — common for institutional, discontinued, or low-volume packs.
Medicaid paysCMS SDUD · 12 mo No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data.
Medicare drug plans payPart D · quarterly No Part D plan price is available for this NDC in our data.
ℹ️
No price is published for this exact package yet. CMS surveys NADAC per package size, so a different pack of the same drug often has one.
Try another pack size: 6 tablets 12 tablets 30 tablets 36 tablets 40 tablets 50 tablets 70 tablets 70 tablets 100 tablets
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

Packaging — all sizes for this product

Package NDCDescription Marketing startMarketing endStatus
63029-0222-01 63029-222-01 Main listing 1 BLISTER PACK in 1 BOX / 30 TABLET in 1 BLISTER PACK 2012-06-01 — Active
63029-0222-02 63029-222-02 1 BLISTER PACK in 1 BOX / 6 TABLET in 1 BLISTER PACK 2012-06-01 — Active
63029-0222-03 63029-222-03 1 BLISTER PACK in 1 BOX / 50 TABLET in 1 BLISTER PACK 2012-06-01 — Active
63029-0222-04 63029-222-04 4 BLISTER PACK in 1 BOX / 10 TABLET in 1 BLISTER PACK 2019-06-01 — Active
63029-0222-05 63029-222-05 4 BLISTER PACK in 1 BOX / 9 TABLET in 1 BLISTER PACK 2019-06-01 — Active
63029-0222-06 63029-222-06 7 BLISTER PACK in 1 BOX / 10 TABLET in 1 BLISTER PACK 2012-06-01 — Active
63029-0222-09 You're viewing this 1 BOTTLE in 1 CARTON / 90 TABLET in 1 BOTTLE 2012-06-01 — Active
63029-0222-11 63029-222-11 1 BOTTLE in 1 CARTON / 100 TABLET in 1 BOTTLE 2012-06-01 — Active
63029-0222-12 63029-222-12 2 BLISTER PACK in 1 BOX / 6 TABLET in 1 BLISTER PACK 2012-06-01 — Active
63029-0222-70 63029-222-70 1 BOTTLE in 1 CARTON / 70 TABLET in 1 BOTTLE 2012-06-01 — Active

Pack size FAQ

What quantity is in this package?
This is a 90-count package — 1 bottle in 1 carton / 90 tablet in 1 bottle.
How does this package differ from NDC 63029-0222-02?
Both are Tagamet Cimetidine 200 mg Tablet — the drug itself is identical. This page's package is the 90-count one, while NDC 63029-0222-02 is the 6 tablets package.
What NDC number is used to bill for this package of Tagamet Cimetidine 200 mg Tablet?
Use the 11-digit billing form listed in the identifiers section of this page. Pharmacy and medical claims use the 11-digit form; the FDA label may print a shorter form of the same code.

Therapeutic equivalents

ProductLabelerPackNADAC/unitTEStatusPrice vs. this
Cimetidine 200 mg 00378-0053-01 Mylan 100 tablets $0.204 AB Availability likely —
Cimetidine 200 mg 62135-0630-30 Chartwell 30 tablets $0.204 AB Availability likely —
Cimetidine 200 mg 69452-0323-20 Bionpharma 100 tablets $0.204 AB Availability likely —
cimetidine 200 acid reducer 200 mg 00363-0022-72 Walgreen 60 tablets — — FDA listed —
Equate Cimetidine 200 mg 49035-0820-72 Wal-Mart 60 tablets — — FDA listed —
Acid Controller 200 mg 51316-0739-76 CVS 120 tablets — — FDA listed —
Tagamet 200 mg 52183-0223-30 Prestige 30 tablets — — FDA listed —
heartburn prevention 200 mg 59640-0022-72 H 60 tablets — — FDA listed —
Cimetidine 200 mg 59651-0823-60 Aurobindo 60000 tablets — AB FDA listed —
heartburn relief 200 mg 59779-0022-72 CVS 60 tablets — — FDA listed —
Tagamet 200 mgthis 63029-0222-09 Medtech 90 tablets — — FDA listed —
Tagamet 200 mg 63029-0223-30 Medtech 30 tablets — — FDA listed —
basic care acid reducer 200 mg 72288-0022-76 Amazon.com 120 tablets — — FDA listed —
Acid Reducer 200 mg 72288-0470-76 Amazon.com 120 tablets — — FDA listed —
About this product: this is the brand-name version. FDA-approved generic versions are listed, and recent pricing/market data suggests they may be available.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

Availability & generic status

🏛️
2012
On the market since
Jun 2012
📍
2026
Currently FDA-listed
14 years listed
🔓
·
Generic versions listed
see equivalents
✅Generic appears available

FDA-approved generic versions are listed, and recent pricing/market data suggests they may be available — see Therapeutic equivalents.

Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

What it looks like

Color white / blue
ShapeDiamond
ImprintTAGAMET;200
Size13 mm
ScoringScored — splits in 2
FlavorPeppermint
One label can cover several strengths, so colors may be combined — always confirm a loose pill against the dispensed prescription label or a pharmacist.
Where does this data come from?
Physical description (imprint, shape, color, scoring, coating) from this product’s FDA Structured Product Labeling (SPL), mirrored from DailyMed / openFDA.

Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

Loading inactive ingredients from the official FDA label in the background. No external source is being called by this page request.
Where does this data come from?
Source: official FDA Structured Product Labeling (SPL) via DailyMed and the openFDA label index. Structured IACT rows and label-wide narrative are kept separate; availability and product-level specificity depend on the submitted label.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

Manufacturer & labeler

LabelerMedtech Products Inc.
Application holderMEDTECH PRODUCTS INC
FDA applicationNDA020238 (NDA)
Labeler code63029
First marketedJun 2012
Product typeHuman Otc Drug
Portfolio57 products on file
The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

FDA label — Drug Facts FDA SPL

The complete FDA label for this product — the official Drug Facts labeling, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage ⏱️ Dosage and Administration ⚠️ Warnings 🧪 Active Ingredient 🧪 Inactive Ingredients 🎯 Purpose
🎯 Indications and Usage 29 words ▾

Uses relieves heartburn associated with acid indigestion and sour stomach prevents heartburn associated with acid indigestion and sour stomach brought on by eating or drinking certain foods and beverages

⏱️ Dosage and Administration 68 words ▾

Directions adults and children 12 years and over: ▪ to relieve symptoms, swallow 1 tablet with a glass of water ▪ to prevent symptoms, swallow 1 tablet with a glass of water right before or any time up to 30 minutes before eating food or drinking beverages that cause heartburn ▪ do not take more than 2 tablets in 24 hours children under 12 years: ask a doctor

⚠️ Warnings 199 words ▾

Warnings Allergy a lert: Do not use if you are allergic to cimetidine or other acid reducers. Do not use if you have trouble or pain swallowing food, vomiting with blood, or bloody or black stools. These may be signs of a serious condition.

See your doctor. with other acid reducers Ask a doctor before use if you have frequent chest pain frequent wheezing, particularly with heartburn unexplained weight loss nausea or vomiting stomach pain had heartburn over 3 months. This may be a sign of a more serious condition. heartburn with lightheadedness, sweating or dizziness chest pain or shoulder pain with shortness of breath; sweating; pain spreading to arms, neck or shoulders; or lightheadedness kidney disease liver disease Ask a doctor or pharmacist before use if you are taking a prescription drug.

Acid reducers may interact with certain prescription drugs. Stop use and ask a doctor if you need to take this product for more than 14 days stomach pain continues your heartburn continues or worsens If pregnant or breast-feeding, ask a health professional before use. Keep out of reach of children.

In case of overdose, get medical help or contact a Poison Control Center (1-800-222-1222) right away.

🧪 Active Ingredient 7 words ▾

Active ingredient (in each tablet) Cimetidine 200mg

🧪 Inactive Ingredients 21 words ▾

Inactive ingredients cellulose, corn starch, hypromellose, magnesium stearate, polyethylene glycol, polysorbate 80, povidone, sodium lauryl sulfate, sodium starch glycolate, titanium dioxide

🎯 Purpose 3 words ▾

Purpose Acid reducer

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗

Medicare Part D spend CMS · PART D · 2026 (Q1)

Medicare Part D (outpatient prescription) spending for Cimetidine (matched by generic name) — the program that covers self-administered drugs. 5 manufacturers.
⚠️ Drug-level data: CMS publishes Part D spending by drug, not by NDC — these figures combine every manufacturer, strength and package size sold under the name Cimetidine. That’s a different level of aggregation than the Medicaid card above, which is specific to this exact 11-digit NDC (pack size included), so the two aren’t directly comparable.
Period
Total Part D spend
$1.06M
Claims incl. refills
21.2K
Beneficiaries
12.9K
Spend / beneficiary
$82.16
Spend / claim
$50.15
Trend by period
💵 About the dollar figures: spending is what Part D plans paid before confidential manufacturer rebates, so the program’s real net cost is lower. A blank patient count means fewer than 11 people — CMS hides counts that small to protect privacy. Source: CMS Medicare Quarterly Part D Spending by Drug (data.cms.gov), updated quarterly.

Reported adverse events (FAERS)

Read carefully: FAERS reports are voluntary and unverified. Counts are not incidence, do not establish causation, are subject to reporting bias, and cannot be used to compare one drug to another. Shown for signal context only. Reports for TAGAMET (this brand).

Top reported reactions

Chronic Kidney Disease1,264
Acute Kidney Injury715
Renal Failure694
Nausea691
Fatigue604
Dyspnoea506
Vomiting492

Age at onset

Neonate4
Infant3
Child12
Adolescent17
Adult720
Elderly328

Reporter sex

9,251 reports
Male · 35%
Female · 65%
Unknown · 0%

Serious outcomes

Hospitalization3,430
Life-threatening571
Reports over time (by year) — tap or hover for the count & year
2020 2022 2024 2026 599 0
Most recent year is provisional (FAERS lags ~3 months).
Where does this data come from?
Adverse-event reports from the FDA Adverse Event Reporting System (FAERS) via openFDA. FAERS reports are voluntary and unverified — counts are not incidence and don’t establish causation.

About this NDC listing & data coverage

Over-the-counter (OTC) product
What data is (and isn’t) available for this NDC — tap to expand
NDC identity (package / product / labeler codes) ✓ Available
Labeler ✓ Available
Product & package description ✓ Available
Marketing category & status ✓ Available
Active ingredient / dosage form / route ✓ Available
FDA label (SPL via DailyMed) ✓ Available
Package photos ✓ Available
Inactive ingredients (structured) — Not published for this NDC The labeler did not submit a structured excipient list, or no SPL is available.
NADAC pharmacy acquisition price (CMS) — Not published for this NDC CMS publishes NADAC only for NDCs reported in its retail-pharmacy survey.
Orange Book / therapeutic-equivalence data — Not published for this NDC Applies only to products approved under an NDA/ANDA; many listings are out of scope.
HCPCS J-code billing crosswalk — Not published for this NDC Most self-administered / retail products have no J-code — that is normal.
Medicaid utilization (CMS SDUD) — Not published for this NDC CMS reports utilization only for NDCs with Medicaid claims above its privacy threshold.
“Not published” reflects what the public FDA / CMS / NLM sources provide for this exact package code — it is a property of the data feeds, not a judgment about the product.

Questions about this listing

Why is there no price listed?
The pricing shown on our NDC pages comes from CMS NADAC, a voluntary survey of retail community pharmacy invoices. CMS does not publish a NADAC for every NDC — packages outside the retail survey (institutional and hospital products, bulk packages, discontinued items, and many OTC items) may never receive one. A missing price reflects the survey's scope, not this product's actual cost, and does not mean the product is free or unavailable.
Is the NDC printed on the package the same as the 11-digit billing NDC?
Yes, they identify this exact package in different formats. The form printed on the packaging and shown on DailyMed is the one the FDA registered. Insurance claims use a fixed 11-digit 5-4-2 format, so the short segment is padded with a leading zero and the dashes are dropped. The Identity section at the top of this page lists each form of this code.
Is this package still being marketed?
Yes, per the latest FDA NDC Directory data on this page: this package is listed as actively marketed, with no marketing end date reported by Medtech Products Inc.. Listing status can change — the directory data on this page refreshes weekly.
Does this product come in other package sizes?
Yes — the FDA directory lists 9 other package presentations of this same product, including 6 tablets (63029-0222-02), 12 tablets (63029-0222-12), 30 tablets (63029-0222-01). Each has its own NDC and its own page — see the package list near the top of this page.
Who lists this product with the FDA?
Medtech Products Inc. is the labeler of record for this NDC — the company under whose FDA-assigned code the package is listed. The labeler may be the manufacturer itself or a distributor marketing the product under its own code.
Do I need a prescription for this product?
This NDC is listed with FDA as an over-the-counter product, so it does not require a prescription. Follow the package directions, and ask your pharmacist if you are unsure whether it is right for you.
This page identifies an FDA-listed package (the NDC) and reports public regulatory and pricing data about the listing. It is reference information, not a medical recommendation — talk to your pharmacist or prescriber about your own medication.
Where does this data come from?
Listing facts (marketing category, packager status, marketing dates) from the FDA openFDA NDC Directory; label availability from DailyMed; pricing coverage from CMS NADAC; equivalence scope from the FDA Orange Book.
← 63029-0211-01 · Medtech 63029-0223-30 · Medtech →
For educational and professional reference only — not medical advice. Pricing reflects published NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.